Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.48
-0.13 (-0.78%)
Nov 18, 2026, 3:00 PM CST

SHA:600521 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
9,5488,5329,4958,2498,1836,603
Other Revenue
55.4555.4552.8759.5482.5640.95
9,6038,5879,5478,3098,2666,644
Revenue Growth
10.27%-10.06%14.91%0.52%24.42%2.44%
Cost of Revenue
4,1273,5873,7383,3763,1802,671
Gross Profit
5,4765,0005,8094,9335,0863,973
Selling, General & Admin
3,0663,1363,1432,5922,5342,448
Research & Development
1,0941,229986.69982.99925.53942.26
Other Operating Expenses
57.2128.8824.935.693.6365.21
Operating Expenses
4,2154,3854,1913,5723,5083,470
Operating Income
1,262615.321,6181,3601,578502.48
Interest Expense
-240.27-233.6-219.8-231.69-220.02-166.34
Interest & Investment Income
221.3144.6353.2239.4825.83180.61
Currency Exchange Gain (Loss)
-36.5-36.576.960.1208.94-50.99
Other Non Operating Income (Expenses)
-78.8-3.88-5.8-5.14-3.91-4.32
EBT Excluding Unusual Items
1,127385.961,5231,2231,589461.44
Impairment of Goodwill
----6.46--
Gain (Loss) on Sale of Investments
-2.6148.74-98.21-162.9-70299.81
Gain (Loss) on Sale of Assets
26.3602.33-0.29-16.1-9.59
Asset Writedown
-31.83-53.6-30.13-32.95-2-0.16
Other Unusual Items
62.7762.7767.0779.928.2335.42
Pretax Income
1,182443.881,4641,1001,509786.93
Income Tax Expense
265.86216.55356.15283.07332.89306.28
Earnings From Continuing Operations
916.16227.331,107817.251,176480.64
Minority Interest in Earnings
29.5939.0711.5213.22-8.256.89
Net Income
945.75266.41,119830.471,168487.54
Net Income to Common
945.75266.41,119830.471,168487.54
Net Income Growth
102.05%-76.19%34.74%-28.88%139.52%-47.57%
Shares Outstanding (Basic)
1,5021,4801,4531,4571,4421,434
Shares Outstanding (Diluted)
1,5021,4801,4531,4571,4601,434
Shares Change
2.81%1.84%-0.26%-0.19%1.80%-1.30%
EPS (Basic)
0.630.180.770.570.810.34
EPS (Diluted)
0.630.180.770.570.800.34
EPS Growth
96.52%-76.62%35.09%-28.75%135.29%-46.88%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
246.86-735.96319.33624.63-1,074-1,496
Free Cash Flow Per Share
0.16-0.500.220.43-0.73-1.04
Dividend Per Share
0.1000.1000.2500.2000.2400.100
Dividend Growth
-60.00%-60.00%25.00%-16.67%140.00%-50.00%
Gross Margin
57.02%58.23%60.85%59.37%61.53%59.80%
Operating Margin
13.14%7.17%16.95%16.37%19.09%7.56%
Profit Margin
9.85%3.10%11.72%9.99%14.13%7.34%
Free Cash Flow Margin
2.57%-8.57%3.35%7.52%-12.99%-22.52%
EBITDA
2,2721,5862,5352,1412,2301,050
EBITDA Margin
23.66%18.46%26.55%25.76%26.98%15.81%
D&A For EBITDA
1,010970.24916.77780.37652.55547.8
EBIT
1,262615.321,6181,3601,578502.48
EBIT Margin
13.14%7.17%16.95%16.37%19.09%7.56%
Effective Tax Rate
22.49%48.79%24.33%25.73%22.06%38.92%
Revenue as Reported
9,6038,5879,5478,3098,2666,644
Advertising Expenses
-1,2241,4171,0361,034999.39